EANM procedure guidelines for brain neurotransmission SPECT/PET using dopamine D2 receptor ligands, version 2.
The guidelines summarize the current views of the European Association of Nuclear Medicine Neuroimaging Committee (ENC). The aims of the guidelines are to assist nuclear medicine practitioners in making recommendations, performing, interpreting and reporting the results of clinical dopamine D2 receptor SPECT or PET studies, and to achieve a high quality standard of dopamine D2 receptor imaging, which will increase the impact of this technique in neurological practice.The present document is an update of the first guidelines for SPECT using D2 receptor ligands labelled with (123)I [1] and was guided by the views of the Society of Nuclear Medicine Brain Imaging Council [2], and the individual experience of experts in European countries. The guidelines intend to present information specifically adapted to European practice. The information provided should be taken in the context of local conditions and regulations.
Division of Nuclear Medicine, University Hospital Leuven, Herestraat 49, 3000, Leuven, Belgium. koen.vanlaere@uzleuven.be
Koen
K
Van Laere
Andrea
A
Varrone
Jan
J
Booij
Thierry
T
Vander Borght
Flavio
F
Nobili
Ozlem L
OL
Kapucu
Zuzana
Z
Walker
Kjell
K
Någren
Klaus
K
Tatsch
Jacques
J
Darcourt
D001921:Brain / Q000000981:diagnostic imaging* / Q000378:metabolism*; D004298:Dopamine / Q000493:pharmacokinetics*; D005062:European Union; D005260:Female; D006801:Humans; D008297:Male; D049268:Positron-Emission Tomography / Q000592:standards*; D017410:Practice Guidelines as Topic; D019275:Radiopharmaceuticals / Q000493:pharmacokinetics; D017448:Receptors, Dopamine D2 / Q000378:metabolism*; D009435:Synaptic Transmission / Q000502:physiology; D015899:Tomography, Emission-Computed, Single-Photon / Q000592:standards*
D019275:Radiopharmaceuticals; D017448:Receptors, Dopamine D2; D004298:Dopamine